Skip to main content
Caplight Logo









Success Bio-Tech Co., Ltd.

Success Bio-Tech Co., Ltd.

Private
JinanHealthcare & Life Scienceshttp://successbio-tech.com/

Last Round

Series B

Oct 14, 2021

Est. Valuation

$283.69M

Total Funding Raised

$17.02M

Company Overview

Success Bio-Tech Co., Ltd. is a medical device company that specializes in the research, development, production, and sale of biomedical materials for surgical hemostasis, anti-adhesion, and tissue engineering.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

biomedical devicehemostatic agentanti-adhesion barriersurgical biomaterialstissue sealantmedtechinterventional embolizationabsorbable medical devicessurgical suppliesmedical device manufacturerophthalmic protectorbiotech manufacturingsurgical innovation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Success Bio-Tech Co., Ltd. Comparables

Compare Success Bio-Tech Co., Ltd. with similar companies based on industry and business-model similarity.

Success Bio-Tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Datsing Bio-Tech Co., Ltd.
86%
FzioMed, Inc.
78%
Guanhao Biotech Co Ltd
76%

Success Bio-Tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 14, 2021
Series AAug 1, 2019

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2021

    Secured Series B funding with Xiamen ITG Group Corp Ltd as an investor.

  • Aug 1, 2019

    Raised $17M in Series A funding.

Success Bio-Tech Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Success Bio-Tech Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Success Bio-Tech Co., Ltd.'s valuation, stock price, and market status.

Is Success Bio-Tech Co., Ltd. a public or private company?

Success Bio-Tech Co., Ltd. is a private company.

What is the current stock price of Success Bio-Tech Co., Ltd.?

Success Bio-Tech Co., Ltd. is a private company with no public stock price. Caplight tracks Success Bio-Tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Success Bio-Tech Co., Ltd. worth (valuation)?

Success Bio-Tech Co., Ltd.'s valuation is estimated at $283.7M based on funding round data.

Can I buy Success Bio-Tech Co., Ltd. stock?

Success Bio-Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Success Bio-Tech Co., Ltd.'s last funding round?

Success Bio-Tech Co., Ltd.'s most recent funding round was Series B on August 1, 2019.

Who are the main investors in Success Bio-Tech Co., Ltd.?

Investor information for Success Bio-Tech Co., Ltd. is not publicly disclosed.

Will Success Bio-Tech Co., Ltd. IPO soon?

No public IPO plans have been announced for Success Bio-Tech Co., Ltd..

How can I track Success Bio-Tech Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Success Bio-Tech Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJinan
Year FoundedN/A
Last FundingOct 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?